Roche Holding | ROG - Market Capitalization


Roche Holding reported CHF219.6B in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 403.83B 5.2B Dec/2025
Alcon AG USD 31.08B 1.97B Dec/2025
Almirall EUR 2.76B 472.53M Dec/2025
Amgen USD 176.25B 24.32B Dec/2025
AstraZeneca USD 288.15B 55.08B Dec/2025
Bayer EUR 36.36B 9.13B Dec/2025
Biogen USD 25.82B 5.28B Dec/2025
Bristol-Myers Squibb USD 109.81B 18.01B Dec/2025
Eli Lilly USD 1.02T 293.84B Dec/2025
Fresenius EUR 27.59B 889.91M Dec/2025
Fresenius Medical Care EUR 11.96B 1.14B Dec/2025
Galapagos EUR 1.85B 76.44M Dec/2025
Genmab DKK 20.48B 1.02B Dec/2025
Gilead Sciences USD 152.28B 14.55B Dec/2025
GlaxoSmithKline GBP 74.36B 10.31B Dec/2025
Hikma Pharmaceutical USD 4.63B 1.42B Dec/2025
Lonza CHF 39.68B 980.61M Jun/2025
Merck EUR 53.3B 5.72B Dec/2025
Merck USD 261.26B 51.62B Dec/2025
Novartis USD 292.21B 26.55B Dec/2025
Orion EUR 8.94B 243.74M Dec/2025
Pfizer USD 141.57B 6.48B Dec/2025
Philips EUR 22.38B 192.58M Dec/2025
Recordati EUR 10.15B 660.84M Dec/2025
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 100.88B 4.46B Dec/2025
UCB EUR 46.41B 13.94B Dec/2025